Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Impact of Different Conditioning Regimens Administered for SCT in Pediatric Chronic Myeloid Leukemia (CML) CML

Études rétrospectives

Leucémie Lymphoïde Chronique (LLC)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Meinolf Suttorp

Hematopoietic stem cell transplantation (HSCT) in patients with Down syndrome

Closed Survey/Study

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Greffe de cellules souches hématopoïétiques (HSCT) chez les patients atteints du syndrome de Down

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Impact of SCT for Histiocytic Sarcoma (HS) in children

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giorgio Ottaviano (London)

Survey about Antiviral Management (DNA viruses) at Pediatric Transplant Centers – PDWP and IDWP, EBMT

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

International report of allogeneic HSCT in PKD

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Elodie Gouache (Paris)

Second malignancies after SCT for Hypodiploid ALL: TP53 mutation

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Laura Bettini (Monza)

ALL study, patients transplanted between 2 and 4 years old

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Krzysztof Kalwak

Use of Letermovir after transplant in pediatric patients

Études rétrospectives

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini (London)

Impact of Donor and Patient CMV Serology for malignant

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Lymphoïde Chronique (LLC)

Autres tumeurs malignes myéloïdes ou lymphoïdes

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Elif Ince (Ankara)

Impact of the acute GVH on outcomes in ALL

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini (London)

Evaluation of Outcomes following Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with High-Risk Acute Myeloid Leukemia:

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Apparentée

Allogénique - Non apparentée

Allogénique - Haplo-identique

Investigateur principal

Akshay Sharma (Memphis, US)